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ECHNICAL NOTE
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arotid  tumor  pathology  is  complex,  involving  a  wide  variety
f  benign  and  malignant  lesions  that  are  hard  to  distinguish
linically.  Indications  for  surgery  depend  on  lesion  histology,
ize  and  location.  Parotid  MRI  and  ﬁne-needle  aspiration
ytology  (FNA)  are  the  two  indispensable  examinations
o  categorize  and  locate  any  parotid  lesion  showing  an
xpansive  aspect  [1,2].
Etiologically,  parotid  masses  correspond,  in  decreasing
rder  of  frequency,  to:
 pleomorphic  adenoma:  a  benign  tumor  requiring  sur-
gical  dissection  due  to  the  two-fold  risk  of  malignant
degeneration  and  of  recurrence,  the  frequency  of  which
increases  with  lesion  size  and  capsule  defect;
 Warthin’s  tumor,  or  adenolymphoma,  to  which  the
attitude  is  becoming  less  and  less  frequently  surgical,
insofar  as  it  can  be  reliably  characterized  on  MRI  or  FNA;
surgery,  for  reasons  of  esthetics  or  comfort,  is  reserved
for  forms  that  are  voluminous  or  involve  painful  episodes
of  inﬂammatory  evolution;
low,  intermediate  or  high  grade  malignant  tumor,
whether  mucoepidermoid  carcinoma,  cystic  adenoid
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oi:10.1016/j.anorl.2011.12.006carcinoma,  adenocarcinoma,  squamous  cell  carcinoma,
undifferentiated  carcinoma  or  lymphoma,  for  which  the
primary  attitude  is  surgical;
 pseudotumor  or  rarer  forms  of  benign  tumor:  lympho-
epithelial  cyst,  oncocytoma,  hemolymphangioma  or
lipoma.
MRI  provides  essential  information  for  preoperative
haracterization  of  parotid  lesions,  if  rigorously  performed
nd  interpreted  [3].
Before  deciding  on  surgery,  the  ENT  physician  should  be
s  attentive  to  the  quality  of  imaging  as  to  the  radiologist’s
iagnosis.
echnique
RI  should  always  be  performed  before  FNA,  due  to  the
isk  of  bleeding  incurred  by  the  latter  [4,5]: the  blood
n  the  lesion  following  hemorrhagic  FNA  interferes  with
he  spontaneous  lesion  signal  in  T1-weighted  sequences
spontaneous  high  signal  intensity  zone)  and  in  T2-weighted
equences,  impacts  the  diffusion  coefﬁcient  as  measured
n  the  hemorrhagic  areas  and  hinders  uptake  assessment
ollowing  gadolinium  injection.
MRI  should  comprise:
served.
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ial  ri
n  in  l
tensFigure  1  Warthin’s  tumor.  1  cm  tissular  lesion  of  the  superﬁc
intensity on  T1-weighted  image;  b:  T2-weighted  axial  slice:  lesio
coefﬁcient map:  ACDr  =  0.8;  d:  perfusion  curve  showing  rapid  in•  a  T1-weighted  sequence  to  explore  for  spontaneous  high
signal  intensity  within  the  lesion,  related  to  intralesional
protein  or  hematic  components,  both  indicating  Warthin’s
tumor  [6]  (Fig.  1);
•
Figure  2  Pleomorphic  adenoma.  35  mm  tissular  formation  of  the
signal intensity  on  T2-weighted  image;  b:  T1-weighted  gadolinium-en
coefﬁcient map:  ACDr  =  1.7;  d:  perfusion  curve  showing  intense  uptaght  parotid:  a:  T1-weighted  axial  slice:  lesion  with  high  signal
ow  signal  intensity  on  T2-weighted  image;  c:  apparent  diffusion
e  uptake  with  wash-out  greater  than  30%. a T2-weighted  sequence  without  fat-saturation  to
compare  signals  between  lesion  and  healthy  parotid
parenchyma:  a  clear  high  signal  intensity  zone  in  the  for-
mer  as  compared  to  the  latter  indicates  benign  tumor
 superﬁcial  left  parotid:  a:  T2-weighted  axial  slice:  clear  high
hanced  fat-sat  axial  slice:  intense  uptake;  c:  apparent  diffusion
ke  with  ascending  plateau.
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migure  3  Cellular  pleomorphic  adenoma.  2  cm  tissular  format
esion in  isosignal  on  T2-weighted  image;  b:  T1-weighted  gad
iffusion coefﬁcient  map:  ACDr  =  1.09;  d:  perfusion  curve  show(pleomorphic  adenoma;  Fig.  2);  intermediate  T2  signal
intensity  may  indicate  either  cellular  pleomorphic  ade-
noma  or  intermediate  grade  tumor  (Figs.  3  and  4);  clear
low  signal  intensity  indicates  malignant  tumor  [3]  (Fig.  5);
•
igure  4  Intermediate-grade  tumor.  Tissular  formation  of  the  sup
2-weighted  image;  b:  T1-weighted  gadolinium-enhanced  fat-sat  a
ap: ACDr  =  1.1;  d:  perfusion  curve  showing  early  uptake  with  washf  the  superﬁcial  right  parotid  lobe:  a:  T2-weighted  axial  slice:
um-enhanced  fat-sat  axial  slice:  intense  uptake;  c:  apparent
tense  uptake  with  ascending  plateau. a diffusion-weighted  sequence  to  study  Brownian  motion
in  the  free  water:  lesions  with  multiple  physiological
barriers  to  motion  of  the  free  water  (multiple  cellular
membranes  in  cellular  tumor)  limit  diffusion  and  show
erﬁcial  right  parotid:  a:  T2-weighted  axial  slice:  low  signal  on
xial  slice:  moderate  uptake;  c:  apparent  diffusion  coefﬁcient
-out  less  than  30%.
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Figure  5  High-grade  tumor.  3  cm  tissular  formation  of  the  superﬁcial  left  parotid  lobe:  a:  T2-weighted  axial  slice:  lesion  in  isosignal
on T2-weighted  image;  b:  T1-weighted  gadolinium-enhanced  fat-sat  axial  slice:  moderate  uptake;  c:  apparent  diffusion  coefﬁcient
 wit
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t
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Tmap: ACDr  =  0.5;  d:  perfusion  curve  showing  descending  plateau
strong  signal  on  diffusion-weighted  sequences.  The  lesion
signal  should  be  compared  to  that  of  the  neighboring  or
contralateral  healthy  parotid  parenchyma,  as  an  appar-
ent  diffusion  coefﬁcient  ratio  (ADCr:  tumor  ADC/healthy
parotid  ADC).  Thus,  clear  a  high  intensity  zone  on  a
diffusion-weighted  sequence  with  ADCr  <  1 indicates  high-
grade  malignancy  (Fig.  5),  while  ADCr  >  1.3  indicates  a
benign  pleomorphic  adenoma  (Fig.  2);  ADCr  between  1
and  1.3  indicates  either  a  cellular  pleomorphic  adenoma
or  intermediate-grade  malignant  tumor  (Figs.  3  and  4)
[3,7—9];  ﬁnally,  ADCr  approximating  0.5  indicates  suspi-
cion  of  lymphoma;
•  a  perfusion-weighted  sequence  —  a  dynamic  sequence
measuring  gadolinium-enhanced  signal  intensity  pixel-by-
pixel  over  time.  The  resulting  perfusion  curve  is  a  key
element  in  lesion  characterization:  pleomorphic  adenoma
(regardless  of  cellularity)  shows  strong  uptake  with  an
ascending  plateau  (Figs.  2  and  3),  while  Warthin’s  tumor
shows  rapid  intense  uptake  and  intense  wash-out,  exceed-
ing  30%  (Fig.  1);  intermediate-grade  tumors  show  intense
uptake  with  a  horizontal  or  descending  plateau  and  wash-
out  less  than  30%  (Fig.  4)  [3,10,11];
•  gadolinium-enhanced  fat-sat  T1-weighted  sequences,  to
contour  the  lesion  and  distinguish  cystic  and  tissular
areas.MRI report
The  report  should  focus  on:
i
p
oh  wash-out  less  than  30%.
 lesion  morphology:
◦  size  and  position  (deep  or  superﬁcial  part  of  the  gland),
relation  to  the  stylo-mastoid  hole  and  retrocondylar
veins  (marking  the  facial  nerve  trajectory),  contour
quality  and  any  extension  into  subcutaneous  soft  tissue
and  maseter  muscle,
◦ presence  or  absence  of  contralateral  lesion,
◦ presence  or  absence  of  adenopathies;
lesion  signal:
◦ on  T1-weighted  sequence,  T2-weighted  sequence
(without  fat-sat),  diffusion-weighted  sequence  with
ADCr,  uptake  on  gadolinium-enhanced  fat-sat  T1-
weighted  sequence,  and  perfusion  sequence  enhance-
ment  curve.
I.e.,  to  provide  all  data  required  for  lesion  characteriza-
ion,  MRI  must  include  the  following  three  elements:
 a T2-weighted  sequence  (without  fat-sat);
 a diffusion-weighted  sequence  with  ADCr;
 a perfusion  sequence  with  enhancement  curve.
The  MRI  interpretation  protocol  should  adhere  to  the
ecision  tree  shown  in  Fig.  6.  The  radiologist’s  diagno-
is  should  match  the  lesion  characteristics  as  presented  in
able  1.When  MRI  indicates  typical  adenolymphoma,  FNA  risks
nducing  an  inﬂammatory  episode  and  should  not  be
erformed:  the  lesion  should  be  monitored  on  MRI
nly.
34  S.  Espinoza,  P.  Halimi
high  signa l 
inten sity on  T1-
weigh ted 
image?
 
No Yes 
Perf usion** :  
Wash-out  > 30 % 
Wart hin's 
tumor 
Clea r high  signa l 
inten sity on T2-weigh ted 
image ( without f at-sat) 
Yes 
Diff usion**: 
ADCr >1.3 
Perf usion**:   
Asc ending  plateau 
Pleo morphic 
adenoma  
No 
Diff usion**:      
ADCr: 1 to 
Perf usion**:     
Descend ing  plateau 
Perf usion**:   
Ascend ing  plateau 
Cell ular 
pleo morphic 
adenoma  
Intermediate-
grade t umor 
Diff usion**:        
ADCr:  <1 
Perf usion**:     
Descend ing  plateau 
Well-contour ed non -cystic N0 
parotid tumor   
Pain?            
FNA be fore MRI? 
No 
Yes 
Perf usion**:   
Wash-out  > 30 % 
Wart hin's 
tumor 
Bleed ing: Re-
MRI  at  1 
month 
High-grade t umor 
Figure  6  Decision  tree  for  non-cystic  parotid  tumor  without  adenopathy.
*This  decision  tree  excludes  purely  cystic  tumors  or  tumors  lacking  an  easily  identiﬁable  tissular  component.  **  On  the  perfusion
and diffusion-weighted  sequences,  particular  attention  should  be  paid  to  the  positioning  of  the  region  of  interest  within  the  tumor,
which must  be  outside  of  the  cystic  areas.
Table  1  Lesion  characteristics  on  MRI.
T2  ADCr  Perfusion  Other
Warthin’s  tumor  Low  or  iso-signal
intensity
Approx.  1 Wash-out  >  30% Hyper
Bilateral
Inferior  pole
Male  >  50  yrs
Smoker
Pleomorphic  adenoma  High  signal  intensity  >  1.3  Ascending  plateau
Cellular pleomorphic  adenoma  Iso-signal  intensity  1  to  1.3  Ascending  plateau
Intermediate-grade  tumor  Iso-  or  low  signal  intensity  1  to  1.3  Wash-out  <  30%
<  1  
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onclusion
arotid  MRI  should  comprise  a  T2-weighted  sequence  (with-
ut  fat-sat),  a  diffusion-weighted  sequence  with  ADCr  and  a
erfusion  sequence  with  enhancement  curve.
Under  these  conditions,  in  more  than  80%  of  cases  MRI
pproximates  histologic  diagnosis  of  parotid  lesions.  When
RI  indicates  typical  adenolymphoma,  FNA  is  unnecessary
nd  monitoring  should  be  on  MRI  alone.isclosure of interest
he  authors  declare  that  they  have  no  conﬂicts  of  interest
oncerning  this  article.Descending  plateau  Poorly  contoured
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